Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 5.23
+0.09 (1.75%)
May 7, 2026, 4:08 PM HKT
Lepu Biopharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 261.36 | -411.38 | -22.1 | -689.05 | -1,011 |
Depreciation & Amortization | 93.57 | 100.03 | 102.43 | 95.45 | 95.25 |
Other Amortization | 0.15 | 0.15 | 0.15 | - | - |
Loss (Gain) From Sale of Assets | -0.91 | 0.01 | - | -0.61 | - |
Loss (Gain) From Sale of Investments | - | - | -220.26 | - | -5.37 |
Loss (Gain) on Equity Investments | 7.51 | 16.44 | 27.34 | 32.23 | 17.7 |
Stock-Based Compensation | - | 4.4 | 18.57 | 30.42 | 113.51 |
Provision & Write-off of Bad Debts | 0.35 | 0.2 | 0.21 | - | - |
Other Operating Activities | -281.22 | 5.73 | -168.87 | 21.97 | 58.61 |
Change in Accounts Receivable | -21.41 | -8.22 | -38.01 | - | -20.37 |
Change in Inventory | -29.04 | 6.63 | -5.35 | 0.12 | -4.62 |
Change in Accounts Payable | -56.96 | 28.52 | 41.48 | 2.55 | 134.56 |
Change in Unearned Revenue | -0.49 | 7.11 | - | - | - |
Change in Other Net Operating Assets | 14.85 | 53.99 | 13.58 | 25.99 | - |
Operating Cash Flow | -12.23 | -196.39 | -250.84 | -480.93 | -621.74 |
Capital Expenditures | -45.41 | -32.92 | -28 | -110.45 | -213.39 |
Sale of Property, Plant & Equipment | 3.99 | - | - | - | - |
Cash Acquisitions | - | - | - | -10 | -100 |
Sale (Purchase) of Intangibles | -73.77 | -28.83 | -13.2 | -5 | -6.12 |
Investment in Securities | 0.06 | - | 125.14 | 50.79 | 315.61 |
Other Investing Activities | 10.11 | - | - | - | - |
Investing Cash Flow | -105.02 | -61.75 | 83.94 | -74.66 | -3.89 |
Long-Term Debt Issued | 795.45 | 584.41 | 403.55 | 437.46 | 146.11 |
Total Debt Issued | 795.45 | 584.41 | 403.55 | 437.46 | 146.11 |
Long-Term Debt Repaid | -577.61 | -488.63 | -383.99 | -88.76 | -15.82 |
Total Debt Repaid | -577.61 | -488.63 | -383.99 | -88.76 | -15.82 |
Net Debt Issued (Repaid) | 217.84 | 95.78 | 19.56 | 348.7 | 130.3 |
Issuance of Common Stock | 428.87 | 213.38 | - | 739.23 | 261.12 |
Other Financing Activities | -84.76 | -77.07 | -96.26 | -55.96 | -11.11 |
Financing Cash Flow | 561.94 | 232.08 | -76.7 | 1,032 | 380.31 |
Foreign Exchange Rate Adjustments | 7.05 | 1.33 | 0.21 | 37.86 | -2.38 |
Net Cash Flow | 451.74 | -24.73 | -243.38 | 514.23 | -247.7 |
Free Cash Flow | -57.64 | -229.31 | -278.84 | -591.38 | -835.12 |
Free Cash Flow Margin | -6.17% | -62.35% | -123.73% | -3797.71% | - |
Free Cash Flow Per Share | -0.03 | -0.14 | -0.17 | -0.36 | -0.55 |
Cash Interest Paid | 28.11 | 28.25 | 29.38 | 21.39 | 9.29 |
Cash Income Tax Paid | 1.5 | - | - | - | - |
Levered Free Cash Flow | -126.82 | -185.07 | -227.17 | -449.59 | -514.38 |
Unlevered Free Cash Flow | -109.22 | -171.54 | -217.99 | -444.93 | -512.69 |
Change in Working Capital | -93.05 | 88.03 | 11.7 | 28.67 | 109.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.